However, CEO Joe Almeida stressed that the earliest that new products could start to ship from the plant is late November.

DEERFIELD, Ill., November 13, 2024--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Jefferies London Healthcare Conference on Wednesday, November 20 ...

DEERFIELD, Ill., November 12, 2024--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Stifel 2024 Healthcare Conference on Monday, November 18, 2024.

Q3 2024 Earnings Call Transcript November 8, 2024 Operator: Good morning, ladies and gentlemen, and welcome to Baxter ...

Baxter International's Q3 2024 adjusted EPS of $0.80 beat estimates, driven by strong Medical Products & Therapies sales and ...

Baxter International Inc. ( NYSE: BAX) Q3 2024 Earnings Conference Call November 8, 2024 8:30 AM ET Clare Trachtman - Senior Vice President, Chief Investor Relations Officer Joe Almeida - Chairman, ...

With a market cap of $18.3 billion, Baxter International Inc. (BAX) operates in the healthcare and medical technology sector.

Stifel Nicolaus analyst Rick Wise maintained a Buy rating on Baxter International (BAX – Research Report) today and set a price target of ...

However, Baxter continues to caution that it still may be mid- to late-November before the products make their way back into the marketplace. The plant experienced significant flooding damage from ...

Diversified and Innovative Product Portfolio: Baxter's strength lies in its diversified range of medical products and ...